Gritstone Oncology Appoints Vice President of Antibody Therapeutics to Spearhead Advances in their Solid Tumor Bispecific Antibody Program into a Lead Optimization Phase 글 내용 전체보기
Launch of Prilosec OTC® (Omeprazole Delayed-Release) in the U.S. Market Announced by Dr. Reddy’s 글 내용 전체보기
Liva Pharmaceuticals Receives USFDA Approval for Supplemental Abbreviated New Drug Application (sANDA), Ranitidine Injection USP 글 내용 전체보기
WuXi Biologics and Oxford BioTherapeutics Expand Partnership With 5 More Antibody Compounds 글 내용 전체보기
